Page 1 of Clinical Trials for MEDA Pharma GmbH [SPONSOR-COLLABORATORS], 20 Total Matches
- 1RecruitingLast Updated: March 19, 2012Condition(s): Radiation-induced Oesophagitis
- 2CompletedLast Updated: December 7, 2010Condition(s): Allergic Rhinitis
- 3CompletedLast Updated: December 7, 2010Condition(s): Allergic Rhinitis
- 4Active, not recruitingLast Updated: March 26, 2012Condition(s): Actinic Keratosis
- 5CompletedLast Updated: December 5, 2011Condition(s): Asthma
- 6CompletedLast Updated: July 29, 2008Condition(s): Diabetic Polyneuropathy
- 7CompletedLast Updated: February 20, 2007Condition(s): Atrial Fibrillation
- 8CompletedLast Updated: September 24, 2008Condition(s): Actinic Keratosis
- 9CompletedLast Updated: August 25, 2011Condition(s): Atopic Dermatitis
- 10Active, not recruitingLast Updated: October 7, 2011Condition(s): Actinic Keratosis
- 11CompletedLast Updated: August 25, 2010Condition(s): Basal Cell Carcinoma
- 12CompletedLast Updated: April 7, 2009Condition(s): Asthma, Exercise-Induced
- 13CompletedLast Updated: February 20, 2007Condition(s): Actinic Keratoses
- 14CompletedLast Updated: November 19, 2010Condition(s): Actinic Keratosis
- 15CompletedLast Updated: September 26, 2008Condition(s): Warts
- 16TerminatedLast Updated: February 21, 2007Condition(s): Atrial Fibrillation
- 17CompletedLast Updated: September 24, 2008Condition(s): Carcinoma, Basal Cell
- 18CompletedLast Updated: September 14, 2009Condition(s): Diabetic Polyneuropathy
- 19CompletedLast Updated: January 5, 2011Condition(s): Genital Warts
- 20CompletedLast Updated: June 30, 2010Condition(s): Actinic Keratosis
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=MEDA+Pharma+GmbH+
